---
title: "Stocks to watch: Far East Orchard, UltraGreen.ai, iX Biopharma"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300889929.md"
description: "Far East Orchard acquires a 42% stake in FEHT managers for S$28.3 million, boosting assets under management to S$3.9 billion. UltraGreen.ai announced board changes, with Nicky Tan replacing Hsieh Fu Hua as lead independent director. iX Biopharma settled A$1.7 million debt by issuing approximately 2.7 million new shares at S$0.5627 each to private investor Vincent Lee."
datetime: "2026-10-05T00:54:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300889929.md)
  - [en](https://longbridge.com/en/news/300889929.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300889929.md)
generator: "portal-rs"
---

# Stocks to watch: Far East Orchard, UltraGreen.ai, iX Biopharma

\[SINGAPORE\] The following companies saw new developments that may affect trading of their securities on Monday (Oct 5):

Far East Orchard , Far East Hospitality Trust (FEHT) : Far East Orchard is acquiring an additional 42 per cent stake in the managers of FEHT for S$28.3 million. This transaction will propel its core assets under management past its S$3 billion target to S$3.9 billion, Far East Orchard announced on Monday. Shares of Far East Orchard ended 1 per cent or S$0.01 higher at S$1.06 on Friday. Shares of FEHT ended at S$0.51, 1.9 per cent or S$0.01 lower.

UltraGreen.ai : The group announced a number of board changes on Friday, as part of its next phase of development. Lead independent director Hsieh Fu Hua stepped down the same day. Nicky Tan, currently an independent director, was appointed lead independent director in his place. Shares of UltraGreen.ai closed down 0.9 per cent or US$0.005 at US$0.565 on Friday, before the news.

iX Biopharma : The Catalist-listed company announced on Monday that it entered into an agreement to settle an outstanding debt of A$1.7 million (US$1.2 million) through the issuance of new ordinary shares. The debt capitalisation agreement was signed on Saturday with Australia-based private businessman Vincent Lee. iX Biopharma will allot and issue close to 2.7 million new shares for S$0.5627 each. Shares of iX Biopharma ended at S$0.56, up 1.8 per cent or S$0.01, on Friday.

### Related Stocks

- [42C.SG](https://longbridge.com/en/quote/42C.SG.md)
- [O10.SG](https://longbridge.com/en/quote/O10.SG.md)
- [ULG.SG](https://longbridge.com/en/quote/ULG.SG.md)
- [Q5T.SG](https://longbridge.com/en/quote/Q5T.SG.md)

## Related News & Research

- [Far East Orchard raises stake in FEHT managers to 75% for S$ 28.3 million](https://longbridge.com/en/news/300886968.md)
- [Far East Orchard crosses S$3 billion AUM target with higher stakes in business trust managers](https://longbridge.com/en/news/300888900.md)
- [Far East Organization to launch The Serra Residences in Novena, priced from S$3,120 psf](https://longbridge.com/en/news/300768288.md)
- [Far East Orchard to buy London freehold site for £60 million for 444-bed student housing project](https://longbridge.com/en/news/300052146.md)
- [Far East Orchard exercises call option to buy remaining 3% stake in HFS for GBP 1.89 million](https://longbridge.com/en/news/299922574.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**